422 related articles for article (PubMed ID: 25602169)
21. Transmembrane segment 11 appears to line the purine permeation pathway of the Plasmodium falciparum equilibrative nucleoside transporter 1 (PfENT1).
Riegelhaupt PM; Frame IJ; Akabas MH
J Biol Chem; 2010 May; 285(22):17001-10. PubMed ID: 20335165
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum: identification of four purine transport activities in intraerythrocytic parasites.
Quashie NB; Dorin-Semblat D; Bray PG; Biagini GA; Doerig C; Ranford-Cartwright LC; De Koning HP
Biochem J; 2008 Apr; 411(2):287-95. PubMed ID: 18215139
[TBL] [Abstract][Full Text] [Related]
23. Identification and functional analysis of the primary pantothenate transporter, PfPAT, of the human malaria parasite Plasmodium falciparum.
Augagneur Y; Jaubert L; Schiavoni M; Pachikara N; Garg A; Usmani-Brown S; Wesolowski D; Zeller S; Ghosal A; Cornillot E; Said HM; Kumar P; Altman S; Ben Mamoun C
J Biol Chem; 2013 Jul; 288(28):20558-67. PubMed ID: 23729665
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium falciparum transfected with ultra bright NanoLuc luciferase offers high sensitivity detection for the screening of growth and cellular trafficking inhibitors.
Azevedo MF; Nie CQ; Elsworth B; Charnaud SC; Sanders PR; Crabb BS; Gilson PR
PLoS One; 2014; 9(11):e112571. PubMed ID: 25392998
[TBL] [Abstract][Full Text] [Related]
25. Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds.
Ortiz D; Guiguemde WA; Johnson A; Elya C; Anderson J; Clark J; Connelly M; Yang L; Min J; Sato Y; Guy RK; Landfear SM
PLoS One; 2015; 10(4):e0123598. PubMed ID: 25894322
[TBL] [Abstract][Full Text] [Related]
26. Nucleoside transport as a potential target for chemotherapy in malaria.
Baldwin SA; McConkey GA; Cass CE; Young JD
Curr Pharm Des; 2007; 13(6):569-80. PubMed ID: 17346175
[TBL] [Abstract][Full Text] [Related]
27. Identification of first-in-class plasmodium OTU inhibitors with potent anti-malarial activity.
Siyah P; Akgol S; Durdagi S; Kocabas F
Biochem J; 2021 Sep; 478(18):3445-3466. PubMed ID: 34486667
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of malaria parasite growth by quinomycin A and its derivatives through DNA-intercalating activity.
Hayase H; Watanabe N; Lim CL; Nogawa T; Komatsuya K; Kita K; Osada H
Biosci Biotechnol Biochem; 2015; 79(4):633-5. PubMed ID: 25471083
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
[TBL] [Abstract][Full Text] [Related]
30. A 2-amino quinoline, 5-(3-(2-(7-chloroquinolin-2-yl)ethenyl)phenyl)-8-dimethylcarbamyl-4,6-dithiaoctanoic acid, interacts with PfMDR1 and inhibits its drug transport in Plasmodium falciparum.
Edaye S; Reiling SJ; Leimanis ML; Wunderlich J; Rohrbach P; Georges E
Mol Biochem Parasitol; 2014 Jun; 195(1):34-42. PubMed ID: 24914817
[TBL] [Abstract][Full Text] [Related]
31. Structure-based design of novel small-molecule inhibitors of Plasmodium falciparum.
Kortagere S; Welsh WJ; Morrisey JM; Daly T; Ejigiri I; Sinnis P; Vaidya AB; Bergman LW
J Chem Inf Model; 2010 May; 50(5):840-9. PubMed ID: 20426475
[TBL] [Abstract][Full Text] [Related]
32. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
[TBL] [Abstract][Full Text] [Related]
33. Identification of druggable small molecule antagonists of the Plasmodium falciparum hexose transporter PfHT and assessment of ligand access to the glucose permeation pathway via FLAG-mediated protein engineering.
Heitmeier MR; Hresko RC; Edwards RL; Prinsen MJ; Ilagan MXG; Odom John AR; Hruz PW
PLoS One; 2019; 14(5):e0216457. PubMed ID: 31071153
[TBL] [Abstract][Full Text] [Related]
34. High-Content Screening of the Medicines for Malaria Venture Pathogen Box for Plasmodium falciparum Digestive Vacuole-Disrupting Molecules Reveals Valuable Starting Points for Drug Discovery.
Tong JX; Chandramohanadas R; Tan KS
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311064
[No Abstract] [Full Text] [Related]
35. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.
Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the autophagy marker protein Atg8 reveals atypical features of autophagy in Plasmodium falciparum.
Navale R; Atul ; Allanki AD; Sijwali PS
PLoS One; 2014; 9(11):e113220. PubMed ID: 25426852
[TBL] [Abstract][Full Text] [Related]
37. Identity of a Plasmodium lactate/H(+) symporter structurally unrelated to human transporters.
Wu B; Rambow J; Bock S; Holm-Bertelsen J; Wiechert M; Soares AB; Spielmann T; Beitz E
Nat Commun; 2015 Feb; 6():6284. PubMed ID: 25669138
[TBL] [Abstract][Full Text] [Related]
38. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
Chaudhary M; Singh V; Anvikar AR; Sahi S
Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
[TBL] [Abstract][Full Text] [Related]
39. A small-molecule inhibitor of the DNA recombinase Rad51 from
Vydyam P; Dutta D; Sutram N; Bhattacharyya S; Bhattacharyya MK
J Biol Chem; 2019 May; 294(20):8171-8183. PubMed ID: 30936202
[TBL] [Abstract][Full Text] [Related]
40. Substrate-analogous inhibitors exert antimalarial action by targeting the Plasmodium lactate transporter PfFNT at nanomolar scale.
Golldack A; Henke B; Bergmann B; Wiechert M; Erler H; Blancke Soares A; Spielmann T; Beitz E
PLoS Pathog; 2017 Feb; 13(2):e1006172. PubMed ID: 28178358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
